BRISIGOTTI, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 2.090
EU - Europa 888
AS - Asia 364
AF - Africa 46
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.406
Nazione #
US - Stati Uniti d'America 2.086
IT - Italia 211
CN - Cina 146
SG - Singapore 141
SE - Svezia 139
IE - Irlanda 131
UA - Ucraina 120
FR - Francia 109
DE - Germania 66
CI - Costa d'Avorio 36
GB - Regno Unito 34
DK - Danimarca 31
TR - Turchia 29
IN - India 22
FI - Finlandia 17
KR - Corea 17
BE - Belgio 13
MA - Marocco 10
BR - Brasile 9
NL - Olanda 7
JP - Giappone 6
CL - Cile 3
EU - Europa 3
CA - Canada 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
MX - Messico 2
PT - Portogallo 2
RU - Federazione Russa 2
SM - San Marino 2
AR - Argentina 1
CH - Svizzera 1
HU - Ungheria 1
PH - Filippine 1
PK - Pakistan 1
VN - Vietnam 1
Totale 3.406
Città #
Chandler 360
Des Moines 185
Fairfield 171
Jacksonville 140
Ashburn 133
Dublin 131
Boardman 112
Wilmington 85
Seattle 80
Singapore 78
Woodbridge 73
New York 70
Houston 62
Cambridge 59
Lawrence 51
Princeton 51
Ann Arbor 50
San Mateo 41
Abidjan 36
Centro 31
Turin 26
San Diego 22
Pune 21
Guangzhou 19
Shanghai 15
Los Angeles 14
Tolentino 14
Ancona 13
Brussels 13
Marche 13
Wuhan 11
London 10
Washington 10
Beijing 9
Ascoli Piceno 8
Menlo Park 7
Norwalk 7
Cagliari 6
Kilburn 6
Dallas 5
Helsinki 5
Huskvarna 5
Wuxi 5
Gainesville 4
Hanover 4
Redwood City 4
Rome 4
Boydton 3
Civitanova Marche 3
Frankfurt am Main 3
Fuzhou 3
Genoa 3
Guarulhos 3
Hangzhou 3
Jiaxing 3
New Bedfont 3
San Bernardo 3
Acton 2
Borgo Maggiore 2
Grottammare 2
Iesi 2
Ivry-sur-seine 2
Jinhua 2
La Chapelle-sur-Erdre 2
Lisbon 2
Lyon 2
Milan 2
Pescara 2
Porto 2
Prescot 2
Reggio Emilia 2
Rieti 2
Southwark 2
St. Petersburg 2
Stockholm 2
Tokyo 2
Zacatecas City 2
Alexandria 1
Ambato 1
Andover 1
Aversa 1
Berlin 1
Bern 1
Bologna 1
Bolton 1
Brasília 1
Budapest 1
Caserta 1
Changsha 1
Chengdu 1
Chiswick 1
Ciampino 1
Clifton 1
Cuenca 1
Dong Ket 1
Edinburgh 1
Fabriano 1
Fayetteville 1
Filottrano 1
Fukuoka 1
Totale 2.372
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 204
Involvement of the oral cavity in psoriasis: results of a clinical study 118
I polimorfismi genetici nel melanoma cutaneo 109
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 88
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 85
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 83
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 79
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 79
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 78
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 78
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 75
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 75
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 74
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 72
Dermoscopic features of conjunctival melanocytic lesions 72
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 72
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 71
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 70
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 70
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 69
Mycosis Fungoides-like Eruption and Infliximab 67
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 66
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 64
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 64
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 64
Relapsing acute generalized exanthematous pustolosis: a guess. 64
Reticulated acanthoma with sebaceous differentiation 64
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 63
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 62
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 61
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 61
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 61
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 60
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 59
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 59
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 57
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 57
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 56
Expression of nicotinamide N-methyltransferase in non-melanoma skin cancers 55
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 55
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 55
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 54
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 53
Topical application of fumaric acid esters improves appearance of nail psoriasis 48
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 46
Phototherapy in Dermatology 45
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 43
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 41
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 36
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 31
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 30
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 24
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 24
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 24
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. 21
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 18
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 15
Totale 3.548
Categoria #
all - tutte 23.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 0 0 0 0 0 0 36 19 37 5 15 38
2020/2021642 32 43 56 7 47 73 105 27 47 65 108 32
2021/2022419 12 75 22 9 16 24 12 40 23 11 69 106
2022/20231.033 80 122 78 87 53 271 3 57 190 5 66 21
2023/2024591 89 11 54 61 70 139 11 27 3 42 7 77
2024/2025355 152 79 29 18 39 37 1 0 0 0 0 0
Totale 3.548